Development of High-Speed nanoPCR Technology for Point-of-Care Diagnosis of COVID-19

A "nanoPCR" technology was developed for the point-of-care (POC) diagnosis of coronavirus disease-19 (COVID-19). This new technology can diagnose the infection within ~20 minutes while retaining the accuracy of conventional reverse transcription polymerase chain reaction (RT-PCR) technology.

A team of researchers led by Professor CHEON Jinwoo, the director of the Center for Nanomedicine (CNM) within the Institute for Basic Science (IBS) in Seoul, South Korea, in collaboration with Professor LEE Jae-Hyun from Yonsei University and Professor LEE Hakho from Massachusetts General Hospital developed a novel nanoPCR technology that can be used for the decentralized, POC diagnosis of COVID-19. The technique uses the same underlying principle as the standard diagnosis method of RT-PCR to detect viral RNA, but it also features a vast improvement in speed using hybrid nanomaterials and a miniaturized form factor which allows portability.

The gold-standard test method for COVID-19 currently used is RT-PCR: a test that amplifies DNA after changing RNA genes into complementary DNAs for detection. RT-PCR has high accuracy, but it takes one to two hours to detect viruses at the centralized facility equipped with bulky instrumentations. The logistics process of cold chain transportation from the sampling sites to the testing facility makes the conventional RT-PCR diagnosis even slower, taking 1 - 2 days to get the results back to the patients.

To overcome the limitations of existing diagnostic methods, the research team utilized a magneto-plasmonic nanoparticle (MPN) that is comprised of magnetic material in its core and a gold shell that exhibits plasmonic effects. By applying MPNs to PCR, they developed 'nanoPCR' which greatly improves the speed of RT-PCR while retaining highly accurate detection. Plasmonic properties of MPN refer to its ability to convert light energy into thermal energy, and by using this it was possible to shorten the thermocycling step of RT-PCR from 1 - 2 hours to within 11 minutes. In addition, the strong magnetic property of MPN allows an external magnetic field to clear MPNs from the PCR solution to allow for fluorescent detection of the amplified genes. The nanoPCR is capable of detecting even a small amount of genes (~3.2 copies/μl) accurately while simultaneously amplifying and detecting genetic material with high sensitivity and specificity.

The researchers tested nanoPCR under clinical settings through the patient specimen tests conducted with Professor CHOI Hyun-Jung's team at Chonnam National University Hospital. During the test, 150 subjects with or without COVID-19 infection were accurately diagnosed using this technology (75 positives, 75 negative samples; zero false-negatives and false-positives). The level of sensitivity and specificity was found to be equivalent to that of the conventional RT-PCR (~99%). In addition to high reliability, the whole diagnostic process was considerably fast, as on average it took about 17 minutes for the diagnosis of one specimen.

In addition, the researchers showed the possibility of improving the analytical throughput by applying a Ferris wheel system to load multiple samples at once, which would allow for simultaneous testing of many samples from multiple patients. Importantly, the nanoPCR equipment is very compact in size (15 × 15 × 18cm) and weight (3 kg), which allows it to be portable. All of this would pave the way for rapid, decentralized testing of patients for the POC diagnosis.

Director Cheon said, "Through the improvement and miniaturization of the PCR technology, we have shown that it is possible to perform PCR based POC diagnosis in the field quickly." The research is currently at a proof-of-concept stage and further developments are needed until it can be used in the field.

Jiyong Cheong, Hojeong Yu, Chang Yeol Lee, Jung-uk Lee, Hyun-Jung Choi, Jae-Hyun Lee, Hakho Lee, Jinwoo Cheon.
Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device.
Nature Biomedical Engineering, 2020. doi: 10.1038/s41551-020-00654-0

Most Popular Now

FDA Authorizes Software that Can Help Id…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer...

Orion Health Supports Professional Recor…

Orion Health is supporting the Professional Record Standards Body's partnership scheme by applying to become a 'quality partner'. The company, which is one of the UK’s leading providers of shared care...

Roche Opens Access to Pathology Imaging …

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue...

App Launched in Multiple Languages to He…

An app is being launched to help patients with long term conditions manage their health via care plans accessed on their phone. Unity, by mobile health provider, Health Fabric, will...

Northumbria Healthcare Picks CliniSys to…

Pathologists at one of England's most innovative trusts have chosen the CliniSys laboratory information system (LIMS) as part of a digital strategy to support its drive to continually improve patient...

A Computer Algorithm Called 'Eva' May Ha…

A prescriptive computer program developed by the USC Marshall School of Business and Wharton School of Business of the University of Pennsylvania for Greece to identify asymptomatic, infected travelers...

Contact-Tracing Apps could Improve Vacci…

Mathematical modeling of disease spread suggests that herd immunity could be achieved with fewer vaccine doses by using Bluetooth-based contact-tracing apps to identify people who have more exposure to others...

University of Oxford and Oracle Cloud Sy…

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford...

Study Finds Telemedicine Appointments Re…

Telemedicine appointments combined with in-person visits significantly reduced the risk of further illness for children with medically complex cases, according to results of a new study by researchers with The...

AI Tool Improves Accuracy of Breast Canc…

A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows. When tested separately on 44,755 already...

Using Internet in Retirement Boosts Cogn…

Using the internet during your retirement years can boost your cognitive function, a new study has found. Researchers from Lancaster University Management School, the Norwegian University Science and Technology and...

FDA Clears First Major Imaging Device Ad…

Today, the U.S. Food and Drug Administration cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly a decade. "Computed tomography is an important medical imaging tool...